BAIT

Welcome to the Brand page for “BAIT”, which is offered here for Therapeutic pharmaceutical for the treatment of autoimmune disease and cancer; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer; cell therapy products, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer;.

Its status is currently believed to be active. Its class is unavailable. “BAIT” is believed to be currently owned by “Bait Therapeutics, Inc.”